30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease
Clinical trial NCT00680017 · COMPLETED
Trial details
- NCT number
- NCT00680017
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2011-04-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.